Send feedback

SHOC2 p.Ser4Arg

c.10A>C · rs397517231 · VCV40635

Benign Expert panel
Classification
Benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 9 submitters
AlphaMissense
likely benign
0.3345 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.208%, amr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
RASopathy

ClinGen expert panel — RASopathy VCEP

Benign for RASopathy. Applied ACMG criteria (verbatim):

BP5 BP4 BA1

Curation rationale (ClinGen, verbatim)

The c.10A>C variant in the SHOC2 gene is a missense variant predicted to cause substitution of serine by arginine at amino acid 4 (p.Ser4Arg). The highest filtering allele frequency in gnomAD v4.1.0 is 0.2286% (124/59742 alleles) in the Admixed American population and therefore meets this criterion (BA1). The computational predictor tool REVEL gives a score of 0.113 and does not predict a damaging effect on SHOC2 function (BP4). This variant has been identified in a patient with an alternate molecular basis for disease (BP5; GeneDx, Partners LMM GTR Lab ID: 26957, 21766 internal data; ClinVar SCV000209046.7, SCV000062455.5). In summary, this variant meets criteria to be classified as benign for autosomal dominant RASopathies based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy Variant Curation Expert Panel: BA1, BP4, BP5 (Specification Version 2.1, 09/17/2024)

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.3345likely benign
REVEL0.113moderately benign-leaning
SaProtLLR -5.46tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 9.3GERP 1.3, phastCons 1
Regional constrainto/e 0.83unconstrained · MANE · 376 bp · p 0.042 · regional, not allelic
Overall
CADD23.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.208% Admixed American · 124/59,742 alleles
Filtering AF 0.178% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.167%
Overall 0.00775% 125/1,613,066 alleles · rare exomes 120/1,460,864 · genomes 5/152,202 · joint denominator
Ancestry group Frequency 1 in
Admixed Americangrpmax 0.208% 482
Remaining individualsnot grpmax-eligible 0.0016% 62,442

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SHOC2
Protein
p.Ser4Arg
Coding
c.10A>C
MANE Select
NM_007373
dbSNP
rs397517231
Type
single nucleotide variant
Location
chr10:110964368 (GRCh38)
Gene constraint
LOEUF 0.201 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 88.00 · 13 PDB
Residue 4
the 'disordered' region
Full SHOC2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/shoc2-p-ser4arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown